EarningsQ3 2022 Earnings Report

Mirum Pharmaceuticals (MIRM) Q3 2022 Earnings Report

0 Followers

MX:MIRM Q3 2022 EPS Results

Actual EPS-$18.62

Consensus EPS-$19.15

Beat/MissBeat by +$0.53

One Year Ago EPS-$28.29

Actual Revenue$342.82M

Expected Revenue$379.84M

Beat/MissMissed by -$37.02M

YoY Revenue Growth+275.60%

QuarterQ3 2022

Date11/09/2022

TimeBefore Open

Conference CallWednesday, November 9, 2022

MX:MIRM Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

MX:MIRM Q3 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-8.93 / -	0.913	―
Aug 05, 2026	2026 (Q2)	-13.56 / -19.35	-2.191	-783.33% (-17.16)
May 06, 2026	2026 (Q1)	-6.66 / -245.16	-5.476	-4376.67% (-239.68)
Feb 25, 2026	2025 (Q4)	1.02 / -1.83	-8.945	79.59% (+7.12)
Nov 04, 2025	2025 (Q3)	-2.56 / 0.91	-5.476	116.67% (+6.39)
Aug 06, 2025	2025 (Q2)	-5.95 / -2.19	-9.492	76.92% (+7.30)
May 07, 2025	2025 (Q1)	-6.02 / -5.48	-9.857	44.44% (+4.38)
Feb 26, 2025	2024 (Q4)	-4.71 / -8.94	-11.5	22.22% (+2.56)
Nov 12, 2024	2024 (Q3)	-8.20 / -5.48	-10.405	47.37% (+4.93)
Aug 07, 2024	2024 (Q2)	-8.62 / -9.49	-35.414	73.20% (+25.92)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed